298 related articles for article (PubMed ID: 36670980)
21. Protein phosphatase 2A and tau: an orchestrated 'Pas de Deux'.
Taleski G; Sontag E
FEBS Lett; 2018 Apr; 592(7):1079-1095. PubMed ID: 29121398
[TBL] [Abstract][Full Text] [Related]
22. WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A.
Moreno CS; Park S; Nelson K; Ashby D; Hubalek F; Lane WS; Pallas DC
J Biol Chem; 2000 Feb; 275(8):5257-63. PubMed ID: 10681496
[TBL] [Abstract][Full Text] [Related]
23. The Effects of PP2A Disruption on ER-Mitochondria Contact and Mitochondrial Functions in Neuronal-like Cells.
Chaiwijit P; Uppakara K; Asavapanumas N; Saengsawang W
Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189629
[TBL] [Abstract][Full Text] [Related]
24. Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease.
Wei H; Zhang HL; Xie JZ; Meng DL; Wang XC; Ke D; Zeng J; Liu R
Curr Med Sci; 2020 Feb; 40(1):1-8. PubMed ID: 32166659
[TBL] [Abstract][Full Text] [Related]
25. Protein phosphatase 2A (PP2A) activation promotes axonal growth and recovery in the CNS.
Cheng P; Chen K; Yu W; Gao S; Hu S; Sun X; Huang H
J Neurol Sci; 2015 Dec; 359(1-2):48-56. PubMed ID: 26671085
[TBL] [Abstract][Full Text] [Related]
26. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
27. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
Basurto-Islas G; Grundke-Iqbal I; Tung YC; Liu F; Iqbal K
J Biol Chem; 2013 Jun; 288(24):17495-507. PubMed ID: 23640887
[TBL] [Abstract][Full Text] [Related]
28. Peptidyl-prolyl isomerase 1 regulates protein phosphatase 2A-mediated topographic phosphorylation of neurofilament proteins.
Rudrabhatla P; Albers W; Pant HC
J Neurosci; 2009 Nov; 29(47):14869-80. PubMed ID: 19940183
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase 2A regulation of GABA
Hleihil M; Balakrishnan K; Benke D
Front Mol Neurosci; 2022; 15():1015906. PubMed ID: 36311027
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase 2A activators reverse age-related behavioral changes by targeting neural cell senescence.
Xing J; Chen K; Gao S; Pousse M; Ying Y; Wang B; Chen L; Wang C; Wang L; Hu W; Lu Y; Gilson E; Ye J
Aging Cell; 2023 Mar; 22(3):e13780. PubMed ID: 36644807
[TBL] [Abstract][Full Text] [Related]
31. N-terminal phosphorylation of protein phosphatase 2A/Bβ2 regulates translocation to mitochondria, dynamin-related protein 1 dephosphorylation, and neuronal survival.
Merrill RA; Slupe AM; Strack S
FEBS J; 2013 Jan; 280(2):662-73. PubMed ID: 22583914
[TBL] [Abstract][Full Text] [Related]
32. Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells.
Rahman MM; Rumzhum NN; Hansbro PM; Morris JC; Clark AR; Verrills NM; Ammit AJ
Cell Signal; 2016 Apr; 28(4):325-34. PubMed ID: 26820662
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease.
Tapias V; González-Andrés P; Peña LF; Barbero A; Núñez L; Villalobos C
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37372013
[TBL] [Abstract][Full Text] [Related]
34. An NMDA receptor signaling complex with protein phosphatase 2A.
Chan SF; Sucher NJ
J Neurosci; 2001 Oct; 21(20):7985-92. PubMed ID: 11588171
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Protein Phosphatase-2A (PP2A) by I1PP2A Leads to Hyperphosphorylation of Tau, Neurodegeneration, and Cognitive Impairment in Rats.
Wang X; Blanchard J; Tung YC; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2015; 45(2):423-35. PubMed ID: 25589718
[TBL] [Abstract][Full Text] [Related]
36. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
Millichap LE; Damiani E; Tiano L; Hargreaves IP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
[TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
Yang W; Wang X; Duan C; Lu L; Yang H
Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic SET induces tau hyperphosphorylation through a decrease of methylated phosphatase 2A.
Chasseigneaux S; Clamagirand C; Huguet L; Gorisse-Hussonnois L; Rose C; Allinquant B
BMC Neurosci; 2014 Jun; 15():82. PubMed ID: 24981783
[TBL] [Abstract][Full Text] [Related]
39. Roles and regulation of protein phosphatase 2A (PP2A) in the heart.
Lubbers ER; Mohler PJ
J Mol Cell Cardiol; 2016 Dec; 101():127-133. PubMed ID: 27832939
[TBL] [Abstract][Full Text] [Related]
40. Folate deficiency induces in vitro and mouse brain region-specific downregulation of leucine carboxyl methyltransferase-1 and protein phosphatase 2A B(alpha) subunit expression that correlate with enhanced tau phosphorylation.
Sontag JM; Nunbhakdi-Craig V; Montgomery L; Arning E; Bottiglieri T; Sontag E
J Neurosci; 2008 Nov; 28(45):11477-87. PubMed ID: 18987184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
